Immunotherapy is treatment that uses a certain part of a person?s immune system to fight diseases which is done by stimulating one?s own immune system to work harder to attack cancer cells or by giving immune system components, such as man-made immune system proteins. Immunotherapy includes treatments that work in different ways. Some boost the body?s immune system in a very general way and others help train the immune system to attack cancer cells specifically.
This report aims to provide a comprehensive presentation of the global market for Immuno-oncology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-oncology Drugs. This report contains market size and forecasts of Immuno-oncology Drugs in global, including the following market information:
Global Immuno-oncology Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Immuno-oncology Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Immuno-oncology Drugs companies in 2022 (%)
The global Immuno-oncology Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Immune Checkpoint Inhibitors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Immuno-oncology Drugs include Amgen, Inc, AstraZeneca, Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Merck & Co., Hoffmann-La Roche AG, Johnson & Johnson and Novartis International AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Immuno-oncology Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immuno-oncology Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Immuno-oncology Drugs Market Segment Percentages, by Type, 2022 (%)
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Oncolytic Virus
Others
Global Immuno-oncology Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Immuno-oncology Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Global Immuno-oncology Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Immuno-oncology Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immuno-oncology Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Immuno-oncology Drugs revenues share in global market, 2022 (%)
Key companies Immuno-oncology Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Immuno-oncology Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie, Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono, Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte
Dendreon Corporation
Agilent Technologies Inc.
Agenus Inc.
Enzo Biochem, Inc.
Lonza Group
Bio-Rad Laboratories, Inc.
Avantor, Inc.
Spring Bank Pharmaceuticals, Inc.
Ferring Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immuno-oncology Drugs, market overview.
Chapter 2: Global Immuno-oncology Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Immuno-oncology Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immuno-oncology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Immuno-oncology Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Immuno-oncology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immuno-oncology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immuno-oncology Drugs Overall Market Size
2.1 Global Immuno-oncology Drugs Market Size: 2022 VS 2029
2.2 Global Immuno-oncology Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Immuno-oncology Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Immuno-oncology Drugs Players in Global Market
3.2 Top Global Immuno-oncology Drugs Companies Ranked by Revenue
3.3 Global Immuno-oncology Drugs Revenue by Companies
3.4 Global Immuno-oncology Drugs Sales by Companies
3.5 Global Immuno-oncology Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Immuno-oncology Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Immuno-oncology Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immuno-oncology Drugs Players in Global Market
3.8.1 List of Global Tier 1 Immuno-oncology Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Immuno-oncology Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Immuno-oncology Drugs Market Size Markets, 2022 & 2029
4.1.2 Immune Checkpoint Inhibitors
4.1.3 Immune System Modulators
4.1.4 Cancer Vaccines
4.1.5 Oncolytic Virus
4.1.6 Others
4.2 By Type - Global Immuno-oncology Drugs Revenue & Forecasts
4.2.1 By Type - Global Immuno-oncology Drugs Revenue, 2018-2023
4.2.2 By Type - Global Immuno-oncology Drugs Revenue, 2024-2029
4.2.3 By Type - Global Immuno-oncology Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Immuno-oncology Drugs Sales & Forecasts
4.3.1 By Type - Global Immuno-oncology Drugs Sales, 2018-2023
4.3.2 By Type - Global Immuno-oncology Drugs Sales, 2024-2029
4.3.3 By Type - Global Immuno-oncology Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Immuno-oncology Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immuno-oncology Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Ambulatory Surgical Centers
5.2 By Application - Global Immuno-oncology Drugs Revenue & Forecasts
5.2.1 By Application - Global Immuno-oncology Drugs Revenue, 2018-2023
5.2.2 By Application - Global Immuno-oncology Drugs Revenue, 2024-2029
5.2.3 By Application - Global Immuno-oncology Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Immuno-oncology Drugs Sales & Forecasts
5.3.1 By Application - Global Immuno-oncology Drugs Sales, 2018-2023
5.3.2 By Application - Global Immuno-oncology Drugs Sales, 2024-2029
5.3.3 By Application - Global Immuno-oncology Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Immuno-oncology Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Immuno-oncology Drugs Market Size, 2022 & 2029
6.2 By Region - Global Immuno-oncology Drugs Revenue & Forecasts
6.2.1 By Region - Global Immuno-oncology Drugs Revenue, 2018-2023
6.2.2 By Region - Global Immuno-oncology Drugs Revenue, 2024-2029
6.2.3 By Region - Global Immuno-oncology Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Immuno-oncology Drugs Sales & Forecasts
6.3.1 By Region - Global Immuno-oncology Drugs Sales, 2018-2023
6.3.2 By Region - Global Immuno-oncology Drugs Sales, 2024-2029
6.3.3 By Region - Global Immuno-oncology Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Immuno-oncology Drugs Revenue, 2018-2029
6.4.2 By Country - North America Immuno-oncology Drugs Sales, 2018-2029
6.4.3 US Immuno-oncology Drugs Market Size, 2018-2029
6.4.4 Canada Immuno-oncology Drugs Market Size, 2018-2029
6.4.5 Mexico Immuno-oncology Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Immuno-oncology Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Immuno-oncology Drugs Sales, 2018-2029
6.5.3 Germany Immuno-oncology Drugs Market Size, 2018-2029
6.5.4 France Immuno-oncology Drugs Market Size, 2018-2029
6.5.5 U.K. Immuno-oncology Drugs Market Size, 2018-2029
6.5.6 Italy Immuno-oncology Drugs Market Size, 2018-2029
6.5.7 Russia Immuno-oncology Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Immuno-oncology Drugs Market Size, 2018-2029
6.5.9 Benelux Immuno-oncology Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Immuno-oncology Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Immuno-oncology Drugs Sales, 2018-2029
6.6.3 China Immuno-oncology Drugs Market Size, 2018-2029
6.6.4 Japan Immuno-oncology Drugs Market Size, 2018-2029
6.6.5 South Korea Immuno-oncology Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Immuno-oncology Drugs Market Size, 2018-2029
6.6.7 India Immuno-oncology Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Immuno-oncology Drugs Revenue, 2018-2029
6.7.2 By Country - South America Immuno-oncology Drugs Sales, 2018-2029
6.7.3 Brazil Immuno-oncology Drugs Market Size, 2018-2029
6.7.4 Argentina Immuno-oncology Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Immuno-oncology Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Immuno-oncology Drugs Sales, 2018-2029
6.8.3 Turkey Immuno-oncology Drugs Market Size, 2018-2029
6.8.4 Israel Immuno-oncology Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Immuno-oncology Drugs Market Size, 2018-2029
6.8.6 UAE Immuno-oncology Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen, Inc
7.1.1 Amgen, Inc Company Summary
7.1.2 Amgen, Inc Business Overview
7.1.3 Amgen, Inc Immuno-oncology Drugs Major Product Offerings
7.1.4 Amgen, Inc Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Amgen, Inc Key News & Latest Developments
7.2 AstraZeneca, Plc
7.2.1 AstraZeneca, Plc Company Summary
7.2.2 AstraZeneca, Plc Business Overview
7.2.3 AstraZeneca, Plc Immuno-oncology Drugs Major Product Offerings
7.2.4 AstraZeneca, Plc Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.2.5 AstraZeneca, Plc Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Major Product Offerings
7.3.4 Bristol-Myers Squibb Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 Celgene Corporation
7.4.1 Celgene Corporation Company Summary
7.4.2 Celgene Corporation Business Overview
7.4.3 Celgene Corporation Immuno-oncology Drugs Major Product Offerings
7.4.4 Celgene Corporation Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Celgene Corporation Key News & Latest Developments
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Company Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company Immuno-oncology Drugs Major Product Offerings
7.5.4 Eli Lilly and Company Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Eli Lilly and Company Key News & Latest Developments
7.6 Merck & Co.
7.6.1 Merck & Co. Company Summary
7.6.2 Merck & Co. Business Overview
7.6.3 Merck & Co. Immuno-oncology Drugs Major Product Offerings
7.6.4 Merck & Co. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Merck & Co. Key News & Latest Developments
7.7 Hoffmann-La Roche AG
7.7.1 Hoffmann-La Roche AG Company Summary
7.7.2 Hoffmann-La Roche AG Business Overview
7.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Major Product Offerings
7.7.4 Hoffmann-La Roche AG Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Hoffmann-La Roche AG Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Immuno-oncology Drugs Major Product Offerings
7.8.4 Johnson & Johnson Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 Novartis International AG
7.9.1 Novartis International AG Company Summary
7.9.2 Novartis International AG Business Overview
7.9.3 Novartis International AG Immuno-oncology Drugs Major Product Offerings
7.9.4 Novartis International AG Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Novartis International AG Key News & Latest Developments
7.10 AbbVie, Inc.
7.10.1 AbbVie, Inc. Company Summary
7.10.2 AbbVie, Inc. Business Overview
7.10.3 AbbVie, Inc. Immuno-oncology Drugs Major Product Offerings
7.10.4 AbbVie, Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.10.5 AbbVie, Inc. Key News & Latest Developments
7.11 Pfizer Inc.
7.11.1 Pfizer Inc. Company Summary
7.11.2 Pfizer Inc. Immuno-oncology Drugs Business Overview
7.11.3 Pfizer Inc. Immuno-oncology Drugs Major Product Offerings
7.11.4 Pfizer Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Pfizer Inc. Key News & Latest Developments
7.12 Sanofi S.A.
7.12.1 Sanofi S.A. Company Summary
7.12.2 Sanofi S.A. Immuno-oncology Drugs Business Overview
7.12.3 Sanofi S.A. Immuno-oncology Drugs Major Product Offerings
7.12.4 Sanofi S.A. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Sanofi S.A. Key News & Latest Developments
7.13 EMD Serono, Inc.
7.13.1 EMD Serono, Inc. Company Summary
7.13.2 EMD Serono, Inc. Immuno-oncology Drugs Business Overview
7.13.3 EMD Serono, Inc. Immuno-oncology Drugs Major Product Offerings
7.13.4 EMD Serono, Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.13.5 EMD Serono, Inc. Key News & Latest Developments
7.14 Gilead Sciences Inc.
7.14.1 Gilead Sciences Inc. Company Summary
7.14.2 Gilead Sciences Inc. Business Overview
7.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Major Product Offerings
7.14.4 Gilead Sciences Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Gilead Sciences Inc. Key News & Latest Developments
7.15 Prometheus Therapeutics & Diagnostics
7.15.1 Prometheus Therapeutics & Diagnostics Company Summary
7.15.2 Prometheus Therapeutics & Diagnostics Business Overview
7.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Major Product Offerings
7.15.4 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Prometheus Therapeutics & Diagnostics Key News & Latest Developments
7.16 Aduro BioTech
7.16.1 Aduro BioTech Company Summary
7.16.2 Aduro BioTech Business Overview
7.16.3 Aduro BioTech Immuno-oncology Drugs Major Product Offerings
7.16.4 Aduro BioTech Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Aduro BioTech Key News & Latest Developments
7.17 Galena Biopharma
7.17.1 Galena Biopharma Company Summary
7.17.2 Galena Biopharma Business Overview
7.17.3 Galena Biopharma Immuno-oncology Drugs Major Product Offerings
7.17.4 Galena Biopharma Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Galena Biopharma Key News & Latest Developments
7.18 Bavarian Nordic
7.18.1 Bavarian Nordic Company Summary
7.18.2 Bavarian Nordic Business Overview
7.18.3 Bavarian Nordic Immuno-oncology Drugs Major Product Offerings
7.18.4 Bavarian Nordic Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Bavarian Nordic Key News & Latest Developments
7.19 Celldex Therapeutics
7.19.1 Celldex Therapeutics Company Summary
7.19.2 Celldex Therapeutics Business Overview
7.19.3 Celldex Therapeutics Immuno-oncology Drugs Major Product Offerings
7.19.4 Celldex Therapeutics Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Celldex Therapeutics Key News & Latest Developments
7.20 ImmunoCellular Therapeutics
7.20.1 ImmunoCellular Therapeutics Company Summary
7.20.2 ImmunoCellular Therapeutics Business Overview
7.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Major Product Offerings
7.20.4 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.20.5 ImmunoCellular Therapeutics Key News & Latest Developments
7.21 Incyte
7.21.1 Incyte Company Summary
7.21.2 Incyte Business Overview
7.21.3 Incyte Immuno-oncology Drugs Major Product Offerings
7.21.4 Incyte Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.21.5 Incyte Key News & Latest Developments
7.22 Dendreon Corporation
7.22.1 Dendreon Corporation Company Summary
7.22.2 Dendreon Corporation Business Overview
7.22.3 Dendreon Corporation Immuno-oncology Drugs Major Product Offerings
7.22.4 Dendreon Corporation Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.22.5 Dendreon Corporation Key News & Latest Developments
7.23 Agilent Technologies Inc.
7.23.1 Agilent Technologies Inc. Company Summary
7.23.2 Agilent Technologies Inc. Business Overview
7.23.3 Agilent Technologies Inc. Immuno-oncology Drugs Major Product Offerings
7.23.4 Agilent Technologies Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.23.5 Agilent Technologies Inc. Key News & Latest Developments
7.24 Agenus Inc.
7.24.1 Agenus Inc. Company Summary
7.24.2 Agenus Inc. Business Overview
7.24.3 Agenus Inc. Immuno-oncology Drugs Major Product Offerings
7.24.4 Agenus Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.24.5 Agenus Inc. Key News & Latest Developments
7.25 Enzo Biochem, Inc.
7.25.1 Enzo Biochem, Inc. Company Summary
7.25.2 Enzo Biochem, Inc. Business Overview
7.25.3 Enzo Biochem, Inc. Immuno-oncology Drugs Major Product Offerings
7.25.4 Enzo Biochem, Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.25.5 Enzo Biochem, Inc. Key News & Latest Developments
7.26 Lonza Group
7.26.1 Lonza Group Company Summary
7.26.2 Lonza Group Business Overview
7.26.3 Lonza Group Immuno-oncology Drugs Major Product Offerings
7.26.4 Lonza Group Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.26.5 Lonza Group Key News & Latest Developments
7.27 Bio-Rad Laboratories, Inc.
7.27.1 Bio-Rad Laboratories, Inc. Company Summary
7.27.2 Bio-Rad Laboratories, Inc. Business Overview
7.27.3 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Major Product Offerings
7.27.4 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.27.5 Bio-Rad Laboratories, Inc. Key News & Latest Developments
7.28 Avantor, Inc.
7.28.1 Avantor, Inc. Company Summary
7.28.2 Avantor, Inc. Business Overview
7.28.3 Avantor, Inc. Immuno-oncology Drugs Major Product Offerings
7.28.4 Avantor, Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.28.5 Avantor, Inc. Key News & Latest Developments
7.29 Spring Bank Pharmaceuticals, Inc.
7.29.1 Spring Bank Pharmaceuticals, Inc. Company Summary
7.29.2 Spring Bank Pharmaceuticals, Inc. Business Overview
7.29.3 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Major Product Offerings
7.29.4 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.29.5 Spring Bank Pharmaceuticals, Inc. Key News & Latest Developments
7.30 Ferring Pharmaceuticals
7.30.1 Ferring Pharmaceuticals Company Summary
7.30.2 Ferring Pharmaceuticals Business Overview
7.30.3 Ferring Pharmaceuticals Immuno-oncology Drugs Major Product Offerings
7.30.4 Ferring Pharmaceuticals Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.30.5 Ferring Pharmaceuticals Key News & Latest Developments
8 Global Immuno-oncology Drugs Production Capacity, Analysis
8.1 Global Immuno-oncology Drugs Production Capacity, 2018-2029
8.2 Immuno-oncology Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Immuno-oncology Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Immuno-oncology Drugs Supply Chain Analysis
10.1 Immuno-oncology Drugs Industry Value Chain
10.2 Immuno-oncology Drugs Upstream Market
10.3 Immuno-oncology Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Immuno-oncology Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Immuno-oncology Drugs in Global Market
Table 2. Top Immuno-oncology Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Immuno-oncology Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Immuno-oncology Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Immuno-oncology Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Immuno-oncology Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Immuno-oncology Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Immuno-oncology Drugs Product Type
Table 9. List of Global Tier 1 Immuno-oncology Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immuno-oncology Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Immuno-oncology Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Immuno-oncology Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Immuno-oncology Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Immuno-oncology Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Immuno-oncology Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Immuno-oncology Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Immuno-oncology Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Immuno-oncology Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Immuno-oncology Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Immuno-oncology Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Immuno-oncology Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Immuno-oncology Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Immuno-oncology Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Immuno-oncology Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Immuno-oncology Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Immuno-oncology Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Immuno-oncology Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Immuno-oncology Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Immuno-oncology Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Immuno-oncology Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Immuno-oncology Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Immuno-oncology Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Immuno-oncology Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Immuno-oncology Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Immuno-oncology Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Immuno-oncology Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Immuno-oncology Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Immuno-oncology Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Immuno-oncology Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Immuno-oncology Drugs Sales, (K Units), 2024-2029
Table 46. Amgen, Inc Company Summary
Table 47. Amgen, Inc Immuno-oncology Drugs Product Offerings
Table 48. Amgen, Inc Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Amgen, Inc Key News & Latest Developments
Table 50. AstraZeneca, Plc Company Summary
Table 51. AstraZeneca, Plc Immuno-oncology Drugs Product Offerings
Table 52. AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. AstraZeneca, Plc Key News & Latest Developments
Table 54. Bristol-Myers Squibb Company Summary
Table 55. Bristol-Myers Squibb Immuno-oncology Drugs Product Offerings
Table 56. Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bristol-Myers Squibb Key News & Latest Developments
Table 58. Celgene Corporation Company Summary
Table 59. Celgene Corporation Immuno-oncology Drugs Product Offerings
Table 60. Celgene Corporation Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Celgene Corporation Key News & Latest Developments
Table 62. Eli Lilly and Company Company Summary
Table 63. Eli Lilly and Company Immuno-oncology Drugs Product Offerings
Table 64. Eli Lilly and Company Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Eli Lilly and Company Key News & Latest Developments
Table 66. Merck & Co. Company Summary
Table 67. Merck & Co. Immuno-oncology Drugs Product Offerings
Table 68. Merck & Co. Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Merck & Co. Key News & Latest Developments
Table 70. Hoffmann-La Roche AG Company Summary
Table 71. Hoffmann-La Roche AG Immuno-oncology Drugs Product Offerings
Table 72. Hoffmann-La Roche AG Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Hoffmann-La Roche AG Key News & Latest Developments
Table 74. Johnson & Johnson Company Summary
Table 75. Johnson & Johnson Immuno-oncology Drugs Product Offerings
Table 76. Johnson & Johnson Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Johnson & Johnson Key News & Latest Developments
Table 78. Novartis International AG Company Summary
Table 79. Novartis International AG Immuno-oncology Drugs Product Offerings
Table 80. Novartis International AG Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Novartis International AG Key News & Latest Developments
Table 82. AbbVie, Inc. Company Summary
Table 83. AbbVie, Inc. Immuno-oncology Drugs Product Offerings
Table 84. AbbVie, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. AbbVie, Inc. Key News & Latest Developments
Table 86. Pfizer Inc. Company Summary
Table 87. Pfizer Inc. Immuno-oncology Drugs Product Offerings
Table 88. Pfizer Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Pfizer Inc. Key News & Latest Developments
Table 90. Sanofi S.A. Company Summary
Table 91. Sanofi S.A. Immuno-oncology Drugs Product Offerings
Table 92. Sanofi S.A. Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Sanofi S.A. Key News & Latest Developments
Table 94. EMD Serono, Inc. Company Summary
Table 95. EMD Serono, Inc. Immuno-oncology Drugs Product Offerings
Table 96. EMD Serono, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. EMD Serono, Inc. Key News & Latest Developments
Table 98. Gilead Sciences Inc. Company Summary
Table 99. Gilead Sciences Inc. Immuno-oncology Drugs Product Offerings
Table 100. Gilead Sciences Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Gilead Sciences Inc. Key News & Latest Developments
Table 102. Prometheus Therapeutics & Diagnostics Company Summary
Table 103. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Offerings
Table 104. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Prometheus Therapeutics & Diagnostics Key News & Latest Developments
Table 106. Aduro BioTech Company Summary
Table 107. Aduro BioTech Immuno-oncology Drugs Product Offerings
Table 108. Aduro BioTech Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Aduro BioTech Key News & Latest Developments
Table 110. Galena Biopharma Company Summary
Table 111. Galena Biopharma Immuno-oncology Drugs Product Offerings
Table 112. Galena Biopharma Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 113. Galena Biopharma Key News & Latest Developments
Table 114. Bavarian Nordic Company Summary
Table 115. Bavarian Nordic Immuno-oncology Drugs Product Offerings
Table 116. Bavarian Nordic Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 117. Bavarian Nordic Key News & Latest Developments
Table 118. Celldex Therapeutics Company Summary
Table 119. Celldex Therapeutics Immuno-oncology Drugs Product Offerings
Table 120. Celldex Therapeutics Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 121. Celldex Therapeutics Key News & Latest Developments
Table 122. ImmunoCellular Therapeutics Company Summary
Table 123. ImmunoCellular Therapeutics Immuno-oncology Drugs Product Offerings
Table 124. ImmunoCellular Therapeutics Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 125. ImmunoCellular Therapeutics Key News & Latest Developments
Table 126. Incyte Company Summary
Table 127. Incyte Immuno-oncology Drugs Product Offerings
Table 128. Incyte Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 129. Incyte Key News & Latest Developments
Table 130. Dendreon Corporation Company Summary
Table 131. Dendreon Corporation Immuno-oncology Drugs Product Offerings
Table 132. Dendreon Corporation Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 133. Dendreon Corporation Key News & Latest Developments
Table 134. Agilent Technologies Inc. Company Summary
Table 135. Agilent Technologies Inc. Immuno-oncology Drugs Product Offerings
Table 136. Agilent Technologies Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 137. Agilent Technologies Inc. Key News & Latest Developments
Table 138. Agenus Inc. Company Summary
Table 139. Agenus Inc. Immuno-oncology Drugs Product Offerings
Table 140. Agenus Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 141. Agenus Inc. Key News & Latest Developments
Table 142. Enzo Biochem, Inc. Company Summary
Table 143. Enzo Biochem, Inc. Immuno-oncology Drugs Product Offerings
Table 144. Enzo Biochem, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 145. Enzo Biochem, Inc. Key News & Latest Developments
Table 146. Lonza Group Company Summary
Table 147. Lonza Group Immuno-oncology Drugs Product Offerings
Table 148. Lonza Group Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 149. Lonza Group Key News & Latest Developments
Table 150. Bio-Rad Laboratories, Inc. Company Summary
Table 151. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Product Offerings
Table 152. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 153. Bio-Rad Laboratories, Inc. Key News & Latest Developments
Table 154. Avantor, Inc. Company Summary
Table 155. Avantor, Inc. Immuno-oncology Drugs Product Offerings
Table 156. Avantor, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 157. Avantor, Inc. Key News & Latest Developments
Table 158. Spring Bank Pharmaceuticals, Inc. Company Summary
Table 159. Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Product Offerings
Table 160. Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 161. Spring Bank Pharmaceuticals, Inc. Key News & Latest Developments
Table 162. Ferring Pharmaceuticals Company Summary
Table 163. Ferring Pharmaceuticals Immuno-oncology Drugs Product Offerings
Table 164. Ferring Pharmaceuticals Immuno-oncology Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 165. Ferring Pharmaceuticals Key News & Latest Developments
Table 166. Immuno-oncology Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 167. Global Immuno-oncology Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 168. Global Immuno-oncology Drugs Production by Region, 2018-2023 (K Units)
Table 169. Global Immuno-oncology Drugs Production by Region, 2024-2029 (K Units)
Table 170. Immuno-oncology Drugs Market Opportunities & Trends in Global Market
Table 171. Immuno-oncology Drugs Market Drivers in Global Market
Table 172. Immuno-oncology Drugs Market Restraints in Global Market
Table 173. Immuno-oncology Drugs Raw Materials
Table 174. Immuno-oncology Drugs Raw Materials Suppliers in Global Market
Table 175. Typical Immuno-oncology Drugs Downstream
Table 176. Immuno-oncology Drugs Downstream Clients in Global Market
Table 177. Immuno-oncology Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Immuno-oncology Drugs Segment by Type in 2022
Figure 2. Immuno-oncology Drugs Segment by Application in 2022
Figure 3. Global Immuno-oncology Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Immuno-oncology Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Immuno-oncology Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Immuno-oncology Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Immuno-oncology Drugs Revenue in 2022
Figure 9. By Type - Global Immuno-oncology Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Immuno-oncology Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Immuno-oncology Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Immuno-oncology Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Immuno-oncology Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Immuno-oncology Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Immuno-oncology Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Immuno-oncology Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Immuno-oncology Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Immuno-oncology Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Immuno-oncology Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Immuno-oncology Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Immuno-oncology Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Immuno-oncology Drugs Sales Market Share, 2018-2029
Figure 23. US Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Immuno-oncology Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Immuno-oncology Drugs Sales Market Share, 2018-2029
Figure 28. Germany Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Immuno-oncology Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Immuno-oncology Drugs Sales Market Share, 2018-2029
Figure 37. China Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Immuno-oncology Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Immuno-oncology Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Immuno-oncology Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Immuno-oncology Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Immuno-oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Immuno-oncology Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Immuno-oncology Drugs by Region, 2022 VS 2029
Figure 54. Immuno-oncology Drugs Industry Value Chain
Figure 55. Marketing Channels
